Chemonucleolysis Requires Chymopapain: Should We Accept Its Unavailability?

Desert Institute for Spine Care logo

The production of chymopapain and its availability in the United States and Europe has been discontinued by its manufacturer. This creates an untenable and unacceptable situation. Our patients are wit

Previous ArticlePosterolateral Endoscopic Excision for Lumbar Disc Herniation Next ArticleClinical Outcome of Posterolateral Endoscopic Surgery for Pyogenic Spondylodiscitis